Central admixture pharmacy services total parenteral nutrition supplies for critically ILL inpatient and neonates use at alexander t. Augusta military medical center, FT. Belvoir, VA
Ended Awarded Last action
- Contract number
- HT001426FE002
- Awardee
-
Central Admixture Pharmacy Services, Inc. UEI NDPWXJSVYVH9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $50,000
Award facts
- Contract value 100% obligated
- $50,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Belvoir, VA 22060, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $50,000 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $50,000 to Central Admixture Pharmacy Services, Inc. (Caps) on October 1, 2025, for the supply of total parenteral nutrition (TPN) solutions for critically ill inpatient and neonatal patients at Alexander T. Augusta Military Medical Center in Fort Belvoir, Virginia. This contract represents a firm fixed-price delivery order issued under Caps' existing $6.5 million Defense Health Agency BPA for compounded admixture medicines and total parenteral nutrition solutions. The award contains no set-aside designation, reflecting Caps' classification as a large business entity. The contract is scheduled for completion by July 14, 2026.
Caps is an Irvine, California-based pharmaceutical compounding organization specializing in the preparation of customized sterile pharmaceutical preparations for federal healthcare agencies. As both a 503A traditional pharmacy and 503B outsourcing facility, the company has established itself as a critical supplier to the Department of Veterans Affairs, Defense Health Agency, National Institutes of Health, Indian Health Service, and Department of the Army Medical Command, with over 50 prime federal contracts awarded since 2019. The company maintains approximately $18.3 million in authorized ceiling values across multiple indefinite delivery vehicles, demonstrating sustained federal demand for its specialized compounded sterile pharmaceutical products and services across military and federal healthcare delivery systems.
Quick answers
Who was awarded contract HT001426FE002?
HT001426FE002 was awarded to Central Admixture Pharmacy Services, Inc. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT001426FE002 worth?
The government has obligated $50,000 on HT001426FE002.
Is contract HT001426FE002 an order under another contract?
Yes. HT001426FE002 is a BPA call under HT001421A0009, a blanket purchase agreement.
Was contract HT001426FE002 competed?
The extent of competition for HT001426FE002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award